X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Sterling Biotech Fact Sheet, Sterling Biotech Financial Results - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Sterling Biotech Fact Sheet   (STEA)

Here is the latest financial fact sheet of Sterling Biotech. For more details, see the Sterling Biotech quarterly results and Sterling Biotech share price and chart.

STERLING BIOTECH Price History

Price Rs 0.8
Mkt Cap Rs m 209
Vol '000 45.1
P/E X -0.4
P/CF X -0.1
EPS (TTM) Rs -2.1
% ch % -4.9
No. of shares m 272.05
% ch week % -4.9
% ch 1-mth % 10.0
% ch 12-mth % -78.6
52 week H/L Rs 5.6/0.7
(As on Nov 5, 2018 (Close))
* Results Consolidated
Excel EXPORT | DO YOU LIKE THESE FACTSHEETS? TELL US!

STERLING BIOTECH Financials

No. of Mths
Year Ending
12
Dec-09
12
Dec-10
12
Dec-11
12
Dec-12
12
Dec-13
5-Yr Chart
Click to enlarge
STERLING BIOTECH EQUITY SHARE DATA
High Rs1701261072011 
Low Rs90902153 
Sales per share (Unadj.) Rs57.560.362.031.226.8 
Earnings per share (Unadj.) Rs9.55.50.7-13.1-15.0 
Diluted earnings per shareRs8.75.40.7-12.9-14.7 
Cash flow per share (Unadj.) Rs14.412.810.2-3.4-5.5 
Dividends per share (Unadj.) Rs0.500.50000 
Adj. dividends per shareRs0.460.490.000.000.00 
Dividend yield (eoy) %0.40.5000 
Book value per share (Unadj.) Rs82.292.093.069.854.9 
Adj. book value per shareRs75.690.691.668.854.0 
Shares outstanding (eoy) m250.20267.87267.87267.87267.87 
Bonus/Rights/Conversions  BCBC--- 
Price / Sales ratio x2.31.81.00.40.3 
Avg P/E ratio x13.719.886.0-1.0-0.5 
P/CF ratio (eoy) x9.08.46.3-3.7-1.3 
Price / Book Value ratio x1.61.20.70.20.1 
Dividend payout %5.39.2000 
Avg Mkt Cap Rs m32,52628,93017,1573,3751,862 
No. of employees `000NANANA1.41.4 
Total wages/salary Rs m402437506537547 
Avg. sales/employee Rs ThNMNMNM6,049.15,303.3 
Avg. wages/employee Rs ThNMNMNM389.0403.8 
Avg. net profit/employee Rs ThNMNMNM-2,534.6-2,959.0 
STERLING BIOTECH INCOME DATA
Net Sales Rs m14,38216,16616,6208,3487,181 
Other income Rs m89106937043 
Total revenues Rs m14,47016,27216,7138,4187,223 
Gross profit Rs m5,0556,9716,3741,476947 
Depreciation Rs m1,2301,9762,5222,5882,543 
Interest Rs m1,4942,3052,7044,1234,377 
Profit before tax Rs m2,4192,7961,241-5,165-5,931 
Minority Interest Rs m00000 
Prior Period Items Rs m179800 
Extraordinary Inc (Exp) Rs m621-631-962-120 
Tax Rs m68671287-1,680-1,924 
Profit after tax Rs m2,3701,462200-3,498-4,007 
Gross profit margin %35.243.138.417.713.2 
Effective tax rate %28.425.57.032.532.4 
Net profit margin %16.59.01.2-41.9-55.8 
STERLING BIOTECH BALANCE SHEET DATA
Current assets Rs m18,51021,69821,81915,22214,335 
Current liabilities Rs m13,28812,55828,22339,28749,809 
Net working cap to sales %36.356.5-38.5-288.3-494.0 
Current ratio x1.41.70.80.40.3 
Inventory Days Days143155222380403 
Debtors Days Days150153159152171 
Net fixed assets Rs m34,00541,07745,87651,84955,432 
Share capital Rs m250268268268268 
"Free" reserves Rs m20,23924,12024,25017,94213,935 
Net worth Rs m20,56424,64924,90918,70814,701 
Long term debt Rs m18,60126,09015,06511,3749,478 
Total assets Rs m55,26266,41471,34570,83773,988 
Interest coverage x2.62.21.5-0.3-0.4 
Debt to equity ratio x0.91.10.60.60.6 
Sales to assets ratio x0.30.20.20.10.1 
Return on assets %7.05.74.10.90.5 
Return on equity %11.55.90.8-18.7-27.3 
Return on capital %11.68.87.5-3.5-6.4 
Exports to sales %31.631.130.926.725.9 
Imports to sales %0.40.30.50.10.2 
Exports (fob) Rs m4,5385,0355,1412,2301,860 
Imports (cif) Rs m545582412 
Fx inflow Rs m4,5385,0355,1412,2301,860 
Fx outflow Rs m708417710825 
Net fx Rs m4,4684,9514,9642,1221,835 
STERLING BIOTECH CASH FLOW
From Operations Rs m -13 3,482 3,697 8,113 1,719 
From Investments Rs m -4,213 -9,940 -7,332 -8,116 -3,148 
From Financial Activity Rs m 4,495 6,749 2,271 -38 1,426 
Net Cashflow Rs m 269 291 -1,364 -42 -3 
* Results Consolidated
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Share Holding

Indian Promoters 33.9%
Foreign collaborators 0.0%
Indian inst/Mut Fund 0.0%
FIIs 9.9%
ADR/GDR 16.9%
Free float 39.3%
Shareholders 21,482
Pledged promoter(s) holding 55.9%
 

Company Information

REGD OFF 43, Atlanta Building, Nariman Point, Mumbai - 400 021
E-MAIL investorscomplain@stergel.com WEB www.sterlingbiopharma.com
TELEPHONE (022) 6630 6732 FAX (022) 2204 1954
SECTOR PHARMACEUTICALS GROUP MISCELLANEOUS
TR AGENT Link Intime India, C13, Pannalal Silk Mills Compd., LBS Marg, Mumbai-78
AUDITOR H. S. Hathi & Co.
CHM: Nitin J. Sandesara (MD) COMP SEC: Megha Chokshi YEAR OF INC: 1900 BSE CODE: 512299 FV (Rs): 1 DIV YIELD (%): -

More Pharmaceuticals Company Fact Sheets:   SOLAR INDUSTRIES  RASOYA PROTEINS  KANORIA CHEMICALS  VINATI ORG.  PI INDUSTRIES  

Compare STERLING BIOTECH With:   SOLAR INDUSTRIES  RASOYA PROTEINS  KANORIA CHEMICALS  VINATI ORG.  PI INDUSTRIES  



Today's Market

Sensex Trades Marginally Higher; Asian Paints & Axis Bank Top Gainers(12:30 pm)

Share markets in India are presently trading on a positive note. Barring IT sector, all sectoral indices are trading in green with stocks in the realty sector and finance sector.

Views on news

Galaxy Surfactants Ltd. (IPO)

Jan 27, 2018

Should you subscribe to the IPO of Galaxy Surfactants Ltd?

More Views on News

Most Popular

It's Almost the Perfect Time to Buy This Safe Stock(The 5 Minute Wrapup)

Dec 6, 2018

My latest StockSelect recommendation ticks all the boxes of a great safe stock.

Patel's Exit, Election Results, and 4 'Must Have' Small Caps in These Exceptional Times(Profit Hunter)

Dec 11, 2018

RBI Governor's resignation is a statement of dissent with the way government is handling the economy's affairs and could lead to some serious market correction. Here's how to make the most of it.

Players in an Oligopoly Should Have Financials Like This(Chart Of The Day)

Dec 7, 2018

This stock has corrected 30% from peak and looks attractive at these valuations.

Should You Deploy Your Savings In Mirae Asset Equity Savings Fund?(Outside View)

Dec 7, 2018

PersonalFN briefly sheds light on the NFO: Mirae Asset Equity Savings Fund and the investment risk associated in it along with its outlook.

Should You Alter Your Mutual Fund Portfolio Based on the Election Results?(Outside View)

Dec 11, 2018

PersonalFN explains why mutual fund houses seem to be in two minds now and what should investors do in these times.

More

Small Investments
BIG Returns

Zero To Millions Guide 2019
Get our special report, Zero To Millions
(2019 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

TRACK STERLING BIOTECH

  • Track your investment in STERLING BIOTECH with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON STERLING BIOTECH

STERLING BIOTECH - DISHMAN PHARMA COMPARISON

COMPARE STERLING BIOTECH WITH

MARKET STATS